| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 02/23/2000 | CN1245169A Nitroketone compound, its preparing process and pharmaceutical composition containing same |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049657C Process for preparing substituted benzopyran derivatives |
| 02/23/2000 | CN1049654C Piperazine derivatives and medicine composition containing same and use thereof |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028092 Salts of N-(4-Oxo-2-(1H-tetrazoyl-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)b enzamide |
| 02/22/2000 | US6028082 For trating psychological disorders |
| 02/22/2000 | US6028034 Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action |
| 02/22/2000 | US6028033 For controlling undesired vegetation |
| 02/22/2000 | CA2081356C Derivatives and analogues of 2-deoxy-2,3-didehydro-n- acetyl neuraminic acid and their use as antiviral agents |
| 02/21/2000 | CA2280596A1 New indan-1-ol derivatives, their preparation method, and pharmaceutical compositions containing them |
| 02/17/2000 | WO2000008775A1 Rf receiver having cascaded filters and an intermediate amplifier stage |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008017A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 02/17/2000 | WO2000008016A1 Paroxetine salts |
| 02/17/2000 | WO2000008015A2 Fsh mimetics for the treatment of infertility |
| 02/17/2000 | WO2000008014A1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect |
| 02/17/2000 | WO2000008007A2 Cyclopentabenzofuran derivatives and their use |
| 02/17/2000 | WO2000007997A1 IMIDAZOLES AND RELATED COMPOUNDS AS α1A AGONISTS |
| 02/17/2000 | WO2000007995A1 SUCCINOYLAMINO LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 02/17/2000 | WO2000007993A1 Substituted isoquinoleines and their use as anticonvulsivants |
| 02/17/2000 | WO2000007544A2 Vitronectin receptor antagonists |
| 02/17/2000 | WO1999058116A3 Novel formulation containing paroxetine |
| 02/17/2000 | WO1999058113A3 Novel formulation containing paroxetine |
| 02/17/2000 | WO1999020261A3 Use of antigunal agents for the topial treatment of fungus-induced mucositis |
| 02/17/2000 | DE19836792A1 Tube bundle reactor, for oxidation reactions, has partitioned headers allowing heat exchange medium supply to the lower header to be combined with co-current passage within the reactor |
| 02/17/2000 | DE19836044A1 New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer |
| 02/17/2000 | DE19834325A1 New benzo-condensed heterocyclic compounds useful in treatment of thrombosis and prevention of vascular occlusion |
| 02/17/2000 | CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | CA2349324A1 Rf receiver having cascaded filters and an intermediate amplifier stage |
| 02/17/2000 | CA2339857A1 Process for the preparation of a non-crystalline anhydrate form of paroxetine hydrochloride |
| 02/17/2000 | CA2339666A1 Vitronectin receptor antagonists |
| 02/17/2000 | CA2339018A1 Fsh mimetics for the treatment of infertility |
| 02/17/2000 | CA2338944A1 Succinoylamino lactams as inhibitors of a.beta. protein production |
| 02/17/2000 | CA2338594A1 Imidazoles and related compounds as .alpha.1a agonists |
| 02/16/2000 | EP0979079A1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244861A Substituted phenyltriazolin (thi) ones and their use as herbicides |
| 02/16/2000 | CN1244860A Cyclic imines as pesticides |
| 02/16/2000 | CN1244799A L-beta-dioxolane uridine analogs and method for treating and preventing virus infections |
| 02/16/2000 | CN1244528A Di- Or triaza-spiral [4,5] decane derivative |
| 02/16/2000 | CN1049434C Aromatic amidine derivatives and method for preparing medicinal salts thereof |
| 02/16/2000 | CN1049430C Sulfonamides and its preparing method and use thereof |
| 02/15/2000 | US6025505 Fluorescent labeling probes for immunoassays, dna sequencing, detecting products of polymerase chain reactions |
| 02/15/2000 | US6025491 Water soluble onium salt of taxo-diterpenoid |
| 02/15/2000 | US6025482 Backbone modified oligonucleotide analogs and preparation thereof through reductive coupling |
| 02/15/2000 | US6025390 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 02/15/2000 | US6025388 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 02/15/2000 | US6025385 Taxane derivatives and drugs containing the same |
| 02/15/2000 | US6025377 1h-1,2,4-triazole derivative. these compounds can also be used to treat viral infections. |
| 02/15/2000 | US6025372 Somatostatin agonists |
| 02/15/2000 | US6025355 Substituted indolinyl and derivatives thereof, neurological injury and neurodegenerative disorders. |
| 02/15/2000 | US6025350 C-4" substituted macrolide antibiotics |
| 02/15/2000 | CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 02/10/2000 | WO2000006597A2 Endogenous constitutively activated g protein-coupled orphan receptors |
| 02/10/2000 | WO2000006585A1 Medicine nitrate salts |
| 02/10/2000 | WO2000006561A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/10/2000 | WO2000006550A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 02/10/2000 | WO2000006545A1 High affinity ligands for nociceptin receptor orl-1 |
| 02/10/2000 | WO2000006544A1 Cyclic amine derivatives and process for the preparation thereof |
| 02/10/2000 | WO2000006169A1 Integrin receptor antagonists |
| 02/10/2000 | WO2000006166A1 5-ht1f antagonists |
| 02/10/2000 | WO2000006140A2 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | WO2000006085A2 Compounds and methods |
| 02/10/2000 | WO2000006082A2 Treatment of anxiety disorders |
| 02/10/2000 | WO2000000489A3 6-(4-arylalkylpiperazin-1-yl)benzodioxane and 6-(4-arylalkylpiperazin-1-yl)chromane derivatives: dopamine receptor subtype specific ligands |
| 02/10/2000 | WO1999063939A3 Multibinding inhibitors of cyclooxygenase-2 |
| 02/10/2000 | DE19835324A1 Cyclopentabenzofuran-Derivate und ihre Verwendung Cyclopentabenzofuran derivatives and their use |
| 02/10/2000 | DE19830060A1 New epothilone derivatives, used as mitosis regulators e.g. for treating malignant tumors, psoriasis or arthritis |
| 02/10/2000 | CA2339123A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 02/10/2000 | CA2338912A1 Medicine nitrate salts |
| 02/10/2000 | CA2338740A1 Treatment of anxiety disorders |
| 02/10/2000 | CA2338697A1 Compounds and methods |
| 02/10/2000 | CA2338330A1 Use of moclobemide for treating certain phsychiatric and medical disorders |
| 02/10/2000 | CA2338275A1 Integrin receptor antagonists |
| 02/10/2000 | CA2335077A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 02/09/2000 | EP0978279A1 Inhibitors of human glycogen phosphorylase |
| 02/09/2000 | EP0977989A1 4-substituted-quinoline derivatives and 4-substitute-quinoline combinatorial libraries |
| 02/09/2000 | EP0977751A1 Somatostatin agonists |
| 02/09/2000 | EP0977750A1 Farnesyltransferase inhibiting quinazolinones |
| 02/09/2000 | EP0977749A1 Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing same |
| 02/09/2000 | EP0977748A1 Substituted benzopyran derivatives for the treatment of inflammation |
| 02/09/2000 | EP0977745A1 Thioaryl sulfonamide hydroxamic acid compounds |
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | CN1244194A Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators |
| 02/09/2000 | CN1244125A Use of cis-hydroxyitraconazole in order to advoid side-effects of itraconazole and hydroxyintraconazole |
| 02/09/2000 | CN1049219C Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
| 02/08/2000 | US6022972 Key intermediate in the synthesis of an endothelin antagonist the synthesis of this key intermediate via an asymmetric conjugate addition reaction. |
| 02/08/2000 | US6022967 Heterocyclic compounds |
| 02/08/2000 | US6022888 Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient |
| 02/08/2000 | US6022886 Endothelin receptor antagonists |
| 02/08/2000 | US6022884 Substituted pyridine compounds and methods of use |
| 02/08/2000 | US6022876 L-β-dioxolane uridine analogs and methods for treating and preventing Epstein-Barr virus infections |
| 02/08/2000 | US6022496 Chromene compound |
| 02/08/2000 | US6022492 Difluorophenyl pyrimidyl pyridine derivatives and the use thereof in liquid crystal mixtures |
| 02/08/2000 | CA2150016C Pyrrolopyrimidines as crf antagonists |
| 02/08/2000 | CA2014467C 3-substituted-2-oxindole derivatives |
| 02/08/2000 | CA2011449C 6-epifumagillols, production and use thereof |
| 02/07/2000 | CA2279732A1 Method of inhibition of human glycogen phosphorylase |
| 02/03/2000 | WO2000005223A2 Heterocyclic derivatives and their use as integrin inhibitors |